ProKidney Corp.
PROK
$3.02
-$0.28-8.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -87.35% | -93.87% | -72.51% | -25.80% | -3.99% |
| Total Depreciation and Amortization | 35.42% | 43.83% | 40.98% | 43.05% | 38.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.49% | 13.83% | 0.77% | -29.77% | -48.02% |
| Change in Net Operating Assets | 567.12% | -18.28% | -76.27% | -181.81% | -130.91% |
| Cash from Operations | 6.29% | -22.87% | -40.28% | -58.57% | -53.56% |
| Capital Expenditure | -3.39% | 13.13% | 13.71% | 83.08% | -486.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 302.85% | 144.62% | 116.88% | 57.85% | 96.94% |
| Cash from Investing | 47.11% | 87.72% | 106.19% | 61.39% | 81.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.85% | -1.92% | -3.85% | -12.77% | 99.85% |
| Issuance of Common Stock | -96.71% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.51% | 1,611.98% | 1,611.97% | 286,851.06% | -74.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -346.09% | 107.16% | 108.96% | 73.55% | -113.10% |